Newsletter Signup | Join Community
Treatment of stage IIB of Hodgkin lymphoma
Increasing the intensity of chemotherapy requiring bone marrow transplant support is demonstrated to cure more patients
Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors
FDA Approves Keytruda® for Adult and Pediatric Patients with Classical Hodgkin
Cancers that begin in cells of the lymph system are referred to as malignant lymphomas
PD-1 Immunotherapy Shows Promise in Hodgkin’s Lymphoma.
Caring for Yourself During Chemotherapy for Hodgkin’s Lymphoma: How to Manage Hair Loss, Dry Skin, and Brittle Nails
Neulasta® Safe and Effective for Hodgkin’s Patients Treated with ABVD Chemotherapy
Hodgkin’s Survivors: Increased Fatigue, Cardiac, and Thyroid Complications
It’s Not Just a Little Fever: Preventing Infection during Therapy for Lymphoma
Our understanding of lymphomas has allowed scientists to find new and unique ways of treating this blood cancer.
Rituxan Active in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma
Among women who are diagnosed with lymphoma during pregnancy, the outcomes for both mother and baby are often good
More Radiation Therapy Is Not Better for Elderly Patients with Hodgkin’s Lymphoma
Chemotherapy Alone Effective for Hodgkin’s Lymphoma.
With advances in personalized medicine, the look and feel of cancer treatment may change dramatically.
Similar Overall Survival with ABVD and BEACOPP for Advanced Hodgkin’s Lymphoma.
Adcetris Approved for Two Types of Lymphoma
Radiation Therapy Improves 10-Year Survival for Patients With Early Hodgkin’s Lymphoma
Children with Favorable-Risk Hodgkin’s Lymphoma May Benefit from Limited Radiation Therapy
Patients with Hodgkin’s at Risk for Heart Attack Later in Life
Patients with Hodgkin’s Lymphoma at Risk for Heart Attack Later in Life.
Limited Therapy May Cure a Significant Fraction of Pediatric Patients with Early-Stage Hodgkin Lymphoma.
Risk of Second Cancers After Hodgkin’s Lymphoma Is Similar Across Treatment Groups
Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma
Reduced Intensity Transplants Show Promise for Hodgkin’s Lymphoma
Panobinostat Promising in Relapsed/Refractory Hodgkin’s Lymphoma
ABVD superior to MEC or Stanford V as HD Treatment
Some Children with Hodgkin’s Disease Can Skip Radiation Therapy
PET/CT Changes Staging and Treatment of Early Lymphoma
ABVD compared to MOPP-EBV-CAD and Standford V regimen in Hodkin's
Increase in Hodgkin’s Lymphoma in HAART Era
Beta 2-Microglobulin May Help Predict Survival in Early-Stage Hodgkin’s
Study Addresses Treatment of Older Hodgkin’s Patients
PET Scans More Effective Than CT in Lymphomas
Chemotherapy plus Radiation Recommended as Standard of Care in Early Hodgkin’s
Family History Associated with Increased Risk of Non-Hodgkin’s and Hodgkin’s Lymphoma
Chemotherapy Regimen ABVD Should be Considered Standard Initial Treatment for Advanced Hodgkin’s
Cardiac Complications Common among Patients who Received Radiation to the Chest for Hodgkin’s Disease
Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas
Smoking May Increase Risk of Hodgkin’s Lymphoma
Patients with Unfavorable Risk Hodgkin’s Lymphoma May Not Benefit from More Intensive Therapy
Gemzar®/Cisplatin/Dexamethasone Effective in Relapsed Hodgkin’s Disease
Successful Treatment for Lymphoma Means Staying on Schedule
Addition of Interferon Following an Stem Cell Transplant Impressive Outcomes
New Monoclonal Antibody Promising in Refractory Hodgkin’s Lymphoma
Interim PET Scan May Predict Outcome of Hodgkin’s Lymphoma Therapy
Increased Doses of Chemotherapy Improves Survival in Advanced Hodgkin's
New Treatment Can Preserve Childbearing in Women with Hodgkin’s Disease
Chemotherapy Plus Radiation Superior to Radiation Only in Early-Stage Hodgkin’s
Epstein-Barr Virus Effects Survival in Hodgkin’s Disease
Radiation Beneficial for Subset of Patients with Advanced Hodgkin’s
PET Scans More Accurately Determine Extent of Hodgkin’s Disease
Epstein-Barr Virus and Survival with Hodgkin’s Lymphoma
Cryopreserved Ovarian Tissue Results in Live Birth in Hodgkin’s Patient
Reduced Radiation Dose May Be Effective for Early Hodgkin’s
High-Dose Chemotherapy Improves Responses for Recurrent Hodgkin’s.
Radiation Therapy Does not Improve Survival for Patients with Hodgkin’s Lymphoma
No Benefit for Involved Field Radiation in Patients who Achieve CR for Stage III-IV Hodgkin’s Lymphoma.
ASCO 2009: Advances in Treatment of Hodgkin’s Lymphoma.
Checkpoint inhibitors Appear Effective in Stem Cell Transplant Recipients.
Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions.
Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma
Routine CT Scans May Not Be Necessary for Many Lymphoma Survivors
CHOP-GR Safe and Effective for Advanced-stage Follicular Lymphoma
Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers.
Patients who have been treated with radiation therapy for Hodgkin’s lymphoma have an elevated risk of stroke.
Study Confirms that Radiation Therapy Is Not Necessary in Patients with Favorable, Limited-stage Hodgkin’s Lymphoma.
Declining Risk of AML After Hodgkin’s Lymphoma
Rituxan® Improves Prognosis Among Patients with Follicular Lymphoma.
Opdivo® Highly Effective for Some Patients with Lymphomas
Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma
Rituxan® Improves Survival in Patients with Follicular Lymphoma
High-Dose Chemotherapy and Autologous Stem Cell Transplantation Improves Responses in Advanced Follicular Lymphoma
Treatment with High-dose Chemotherapy, Autologous Transplant, and Radiation Effective for Primary CNS Lymphoma
Ocular Adnexal Lymphoma Increasing in Frequency
NDA Submitted for Pralatrexate for Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma.
Stem Cell Transplants Improve Survival in Recurrent Peripheral T-Cell Lymphoma
Keytruda PD-1 Immunotherapy Shows Promise in Hodgkin’s Lymphoma
Gemzar®/Navelbine® Effective and Well-tolerated in Children with Relapsed/Refractory Hodgkin’s Disease
Mini Allogeneic Transplantation Feasible for HIV-Related Lymphomas
Did your doctor offer "prophylatic" GCSF with your Adcetris treatment? New data says they should..